Callens-Clincke financials
A multi-period view of the public annual-account figures reported for Callens-Clincke, with comparable measures and links to available source documents.
Company overviewRegistry number
0754562604
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 29, 2026
Financial evidence
Latest movements for Callens-Clincke
2025 versus 2024
- Operating line
- €426,373
- EBITDA
- €202,529
- Total assets
- €404,473
- Equity
- €115,899
+13.8%
+6%
-25.3%
-47.7%
EBITDA margin +47.5% · Equity ratio +28.7%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202530 Jun 2025 | €426,373 | €202,529 | €404,473 | €115,899 | - |
| 202430 Jun 2024 | €374,604 | €191,054 | €541,141 | €221,803 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.